Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis

Abstract Background Previous studies have reported SIRT1 was inversely modulated by miR‐34a, However, mechanism of metformin (MFN)'s renal podocyte protection under high glucose (HG) conditions and the connection between miR‐34a and SIRT1 expression in diabetic nephropathy (DN) remain unclear....

Full description

Bibliographic Details
Main Authors: Xudong Zhuang, Zhuye Sun, Huasheng Du, Tianhui Zhou, Jing Zou, Wei Fu
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.1053
_version_ 1797346785189953536
author Xudong Zhuang
Zhuye Sun
Huasheng Du
Tianhui Zhou
Jing Zou
Wei Fu
author_facet Xudong Zhuang
Zhuye Sun
Huasheng Du
Tianhui Zhou
Jing Zou
Wei Fu
author_sort Xudong Zhuang
collection DOAJ
description Abstract Background Previous studies have reported SIRT1 was inversely modulated by miR‐34a, However, mechanism of metformin (MFN)'s renal podocyte protection under high glucose (HG) conditions and the connection between miR‐34a and SIRT1 expression in diabetic nephropathy (DN) remain unclear. Method We aimed to further elucidate the role of miR‐34a in HG‐treated podocytes in DN. A conditionally immortalized human podocyte cell line was cultivated in d‐glucose (30 mM). Results Microarray and RT‐qPCR revealed that miR‐34a was downregulated in HG‐treated podocytes. Additionally, miR‐34a levels increased in MFN‐treated HG‐induced podocytes. CCK‐8 assay, colony formation assay, flow cytometry, and Western blot detection showed that HG treatment reduced cell viability and promoted via HG treatment, and MFN treatment reversed this phenotypic change. MiR‐34a upregulation caused restored cell viability and suppressed cell apoptosis in HG‐treated podocytes, and miR‐34a downregulation led to damaged cell survival and induced apoptosis in MFN‐administered and HG‐treated podocytes. The dual luciferase reporter assay showed that SIRT1 3′‐UTR was a direct miR‐34a target. Further studies demonstrated an elevation in SIRT1 levels in HG‐exposed podocytes, whereas MFN treatment decreased SIRT1 levels. In addition, miR‐34a upregulation led to reduced SIRT1 expression, whereas miR‐34a inhibition increased SIRT1 levels in cells. MFN‐induced miR‐34a suppresses podocyte apoptosis under HG conditions by acting on SIRT1. Conclusion This study proposes a promising approach to interpret the mechanisms of action of the MFN‐miR‐34a axis involved in DN.
first_indexed 2024-03-08T11:38:01Z
format Article
id doaj.art-2005a7ff1c564851a43480dc0a276151
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-03-08T11:38:01Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-2005a7ff1c564851a43480dc0a2761512024-01-25T11:02:19ZengWileyImmunity, Inflammation and Disease2050-45272024-01-01121n/an/a10.1002/iid3.1053Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axisXudong Zhuang0Zhuye Sun1Huasheng Du2Tianhui Zhou3Jing Zou4Wei Fu5Department of Dialysis Linyi Traditional Chinese Medicine Hospital Linyi Shandong ChinaDepartment of Pharmacy Rizhao Hospital of Traditional Chinese Medicine Rizhao Shandong ChinaDepartment of Nephrology Qingdao Municipal Hospital Qingdao Shandong ChinaBeijing University of Chinese Medicine Beijing ChinaDepartment of Dialysis Linyi Traditional Chinese Medicine Hospital Linyi Shandong ChinaDepartment of Drug Dispensing Zibo Central Hospital Zibo Shandong ChinaAbstract Background Previous studies have reported SIRT1 was inversely modulated by miR‐34a, However, mechanism of metformin (MFN)'s renal podocyte protection under high glucose (HG) conditions and the connection between miR‐34a and SIRT1 expression in diabetic nephropathy (DN) remain unclear. Method We aimed to further elucidate the role of miR‐34a in HG‐treated podocytes in DN. A conditionally immortalized human podocyte cell line was cultivated in d‐glucose (30 mM). Results Microarray and RT‐qPCR revealed that miR‐34a was downregulated in HG‐treated podocytes. Additionally, miR‐34a levels increased in MFN‐treated HG‐induced podocytes. CCK‐8 assay, colony formation assay, flow cytometry, and Western blot detection showed that HG treatment reduced cell viability and promoted via HG treatment, and MFN treatment reversed this phenotypic change. MiR‐34a upregulation caused restored cell viability and suppressed cell apoptosis in HG‐treated podocytes, and miR‐34a downregulation led to damaged cell survival and induced apoptosis in MFN‐administered and HG‐treated podocytes. The dual luciferase reporter assay showed that SIRT1 3′‐UTR was a direct miR‐34a target. Further studies demonstrated an elevation in SIRT1 levels in HG‐exposed podocytes, whereas MFN treatment decreased SIRT1 levels. In addition, miR‐34a upregulation led to reduced SIRT1 expression, whereas miR‐34a inhibition increased SIRT1 levels in cells. MFN‐induced miR‐34a suppresses podocyte apoptosis under HG conditions by acting on SIRT1. Conclusion This study proposes a promising approach to interpret the mechanisms of action of the MFN‐miR‐34a axis involved in DN.https://doi.org/10.1002/iid3.1053DNmetforminmiR‐34apodocyteSIRT1
spellingShingle Xudong Zhuang
Zhuye Sun
Huasheng Du
Tianhui Zhou
Jing Zou
Wei Fu
Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
Immunity, Inflammation and Disease
DN
metformin
miR‐34a
podocyte
SIRT1
title Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
title_full Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
title_fullStr Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
title_full_unstemmed Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
title_short Metformin inhibits high glucose‐induced apoptosis of renal podocyte through regulating miR‐34a/SIRT1 axis
title_sort metformin inhibits high glucose induced apoptosis of renal podocyte through regulating mir 34a sirt1 axis
topic DN
metformin
miR‐34a
podocyte
SIRT1
url https://doi.org/10.1002/iid3.1053
work_keys_str_mv AT xudongzhuang metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis
AT zhuyesun metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis
AT huashengdu metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis
AT tianhuizhou metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis
AT jingzou metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis
AT weifu metformininhibitshighglucoseinducedapoptosisofrenalpodocytethroughregulatingmir34asirt1axis